6+ day, 1+ hour ago   (661+ words) As betting expands into clinical trial outcomes, drugmakers may need to look beyond employees and scrutinize outside partners with access to sensitive information. Prediction markets have made it possible to trade on increasingly specific real-world outcomes. But they’ve also opened…...

1+ week, 4+ day ago   (438+ words) Superluminal Medicines banked $60 million in funding to support development of a drug designed to work similarly to — but potentially be more selective than — Rhythm Pharmaceuticals’ Imcivree. Superluminal Medicines, an AI drug discovery startup, has raised another $60 million to give its…...

3+ week, 2+ day ago   (360+ words) When did “we believe we reached physicians” become an acceptable standard for a billion-dollar industry? Somewhere along the way, pharma marketing made peace with probabilistic targeting, inferred identities, and impression counts that looked impressive but proved little. The industry didn’t…...

3+ week, 5+ day ago   (454+ words) The pharmaceutical industry is facing a paradox: markets can grow in value while treating fewer patients. Mexico illustrates this shift clearly. Its pharmaceutical market reached US$22.6 billion in MAT March 2026, growing 6.7% in value while declining 2.2% in units. In other words,…...